Literature DB >> 12746225

Ethanol withdrawal hyper-responsiveness mediated by NMDA receptors in spinal cord motor neurons.

Hui-Fang Li1, Joan J Kendig.   

Abstract

1. Following ethanol (EtOH) exposure, population excitatory postsynaptic potentials (pEPSPs) in isolated spinal cord increase to a level above control (withdrawal hyper-responsiveness). The present studies were designed to characterize this phenomenon and in particular to test the hypothesis that protein kinases mediate withdrawal. 2. Patch-clamp studies were carried out in motor neurons in rat spinal cord slices. Currents were evoked by brief pulses of glutamate, alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) or N-methyl-D-aspartic acid (NMDA). 3. Of 15 EtOH-sensitive neurons in which currents were evoked by glutamate, four (27%) displayed withdrawal hyper-responsiveness in the washout period. Mean current area after washout was 129.6+/-5% of control. 4. When currents were evoked by AMPA, two of 10 neurons (20%) displayed withdrawal hyper-responsiveness, with a mean current area 122+/-8% of control on washout. 5. Of a group of 11 neurons in which currents were evoked by NMDA, nine (82%) displayed withdrawal hyper-responsiveness. Mean increase in current area at the end of the washout period was to 133+/-6% of control (n=9, P<0.001). When NMDA applications were stopped during the period of EtOH exposure, mean area of NMDA-evoked responses on washout was only 98.0+/-5% of control (n=6, P>0.05). 6. The tyrosine kinase inhibitor genistein (10-20 microM) blocked withdrawal hyper-responsiveness. Of six EtOH-sensitive neurons, the mean NMDA-evoked current area after washout was 89+/-6% of control, P>0.05. 7 The protein kinase A (PKA) inhibitor Rp-cAMP (20-500 microM) did not block withdrawal hyper-responsiveness. On washout, the mean NMDA-evoked current area was 124+/-6% of control (n=5, P<0.05). 8 Two broad-spectrum specific protein kinase C (PKC) inhibitors, GF-109203X (0.3 microM) and chelerythrine chloride (0.5-2 nM), blocked withdrawal hyper-responsiveness. Responses on washout were 108+/-7%, n=5 and 88+/-4%, n=4 of control, respectively, P>0.05. 9 NMDA activation during EtOH exposure is necessary for withdrawal hyper-responsiveness. Both tyrosine kinase and PKC, but not PKA, appear to be essential for EtOH withdrawal hyper-responsiveness mediated by postsynaptic NMDA receptors in spinal cord motor neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746225      PMCID: PMC1573814          DOI: 10.1038/sj.bjp.0705198

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain.

Authors:  J Mao; D J Mayer
Journal:  Ann N Y Acad Sci       Date:  2001-03       Impact factor: 5.691

2.  Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors.

Authors:  G Cheng; J J Kendig
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

3.  A Short Alcohol Withdrawal Scale (SAWS): development and psychometric properties.

Authors:  Michael Gossop; Francis Keaney; Duncan Stewart; E Jane Marshall; John Strang
Journal:  Addict Biol       Date:  2002-01       Impact factor: 4.280

4.  Reduced ethanol withdrawal severity and altered withdrawal-induced c-fos expression in various brain regions of mice lacking protein kinase C-epsilon.

Authors:  M F Olive; K K Mehmert; M A Nannini; R Camarini; R O Messing; C W Hodge
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Enflurane actions on spinal cords from mice that lack the beta3 subunit of the GABA(A) receptor.

Authors:  S M Wong; G Cheng; G E Homanics; J J Kendig
Journal:  Anesthesiology       Date:  2001-07       Impact factor: 7.892

Review 6.  Cellular memory in spinal nociceptive circuitry.

Authors:  Lars Jørgen Rygh; Arne Tjølsen; Kjell Hole; Frode Svendsen
Journal:  Scand J Psychol       Date:  2002-04

7.  Increased sensitivity to NMDA is involved in alcohol-withdrawal induced cytotoxicity observed in primary cultures of cortical neurones chronically pre-treated with ethanol.

Authors:  József Nagy; Lajos László
Journal:  Neurochem Int       Date:  2002-06       Impact factor: 3.921

8.  Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain.

Authors:  M al Qatari; S Khan; B Harris; J Littleton
Journal:  Alcohol Clin Exp Res       Date:  2001-09       Impact factor: 3.455

9.  Theophylline blocks ethanol withdrawal-induced hyperalgesia.

Authors:  Michael B Gatch; Meghan Selvig
Journal:  Alcohol Alcohol       Date:  2002 Jul-Aug       Impact factor: 2.826

10.  Pre- and postsynaptic volatile anaesthetic actions on glycinergic transmission to spinal cord motor neurons.

Authors:  Gong Cheng; Joan J Kendig
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

View more
  4 in total

Review 1.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Protein kinase Cgamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons.

Authors:  Hui-Fang Li; Daria Mochly-Rosen; Joan J Kendig
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Ethanol inhibits persistent activity in prefrontal cortical neurons.

Authors:  Yali Tu; Sven Kroener; Kenneth Abernathy; Christopher Lapish; Jeremy Seamans; L Judson Chandler; John J Woodward
Journal:  J Neurosci       Date:  2007-04-25       Impact factor: 6.167

4.  Phenolic compounds protect cultured hippocampal neurons against ethanol-withdrawal induced oxidative stress.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai; James W Simpkins; Marianna E Jung
Journal:  Int J Mol Sci       Date:  2009-04-20       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.